(HealthDay)—For patients undergoing anterior cervical fusion (ACF), three-or-more-level fusions significantly predict the risk of unplanned reintubation, according to a study published in the Jan. 15 issue of Spine.
Jan 23, 2014
0
0
(HealthDay)—Efforts to reduce "adverse events" that occur in the hospital appear to be taking hold for patients who've had a heart attack or those being treated for congestive heart failure, according to new research.
Jan 22, 2014
0
0
A new study by researchers at Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) found comparable long-term outcomes between congestive heart failure patients with preserved ejection fraction commonly ...
Jan 9, 2014
0
0
For the 133 million Americans living with chronic conditions, the best holiday gift is something that will make navigating a daily routine easier. There are almost 40 million people age 65 and older, making up almost 13 percent ...
Dec 18, 2013
0
0
A remarkable 98.7 percent of certain lower-risk breast cancer patients were cancer free for at least three years after taking a combination of the drugs Herceptin and Taxol, a study has found.
Dec 11, 2013
0
0
Cardiovascular complications and hypoglycemia (low blood sugar) were common nonfatal complications in adults 60 years of age and older with diabetes, according to a study published by JAMA Internal Medicine.
Dec 9, 2013
0
0
Cell biologist Jeanne Lawrence's revolutionary recent discovery of a gene that effectively turns off the chromosome responsible for Down syndrome set the scientific world abuzz. On Monday night at Northeastern, she described ...
Dec 4, 2013
0
0
Red blood cell (RBC) transfusions should be restricted to those individuals with severe anemia in patients with heart disease, the American College of Physicians (ACP) recommends in a new clinical practice guideline published ...
Dec 2, 2013
0
0
Researchers from the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai reported the long-term benefits of a single dose of their gene therapy AAV1/SERCA2a in advanced heart failure patients on Nov. ...
Nov 19, 2013
0
0
A new generation of cardiac devices scheduled for human trials in Europe and the United States next year has heart surgeons talking about a possible sea change in the treatment of patients suffering from the most severe level ...
Nov 15, 2013
0
0
